Studieoverzicht

Study name: IPON-1

Histology NSCLC
Tumor stage Stage I - III
Host / recruiting sites MUMC+
Key inclusion criteria

Inclusion criteria (let op korte versie, zie full protocol voor details)

  • Male or female, aged 18 years or above
  • Scheduled to receive one of the following two therapeutic strategies:
    Concurrent chemotherapy and radiotherapy with photons (60 Gy in 30 fractions of 2 Gy) in patients with stage III NSCLC
    Concurrent chemotherapy and radiotherapy with protons (60 Gy in 30 fractions of 2 Gy) in patients with stage III NSCLC
Key exclusion criteria

Exclusion criteria

  • Mixed non-small cell lung cancer with other histologies such as small cell lung cancer
  • Not able to comply with the study protocol
  • Previous radiotherapy to the chest for benign or malignant conditions, including radiation for breast cancer
  • Previous malignancy treated with chemotherapy, immune therapy or radiotherapy (irrespective of when this happened)
  • Previous malignancies treated with surgery only are allowed if 2 years or more before inclusion in the present study
Contact information